Nakayama M - Search Results

1

Novel haemodialysis (HD) treatment employing molecular hydrogen (H₂)-enriched dialysis solution improves prognosis of chronic dialysis patients: A prospective observational study.

Nakayama M, Itami N, Suzuki H, Hamada H, Yamamoto R, Tsunoda K, Osaka N, Nakano H, Maruyama Y, Kabayama S, Nakazawa R, Miyazaki M, Ito S. Nakayama M, et al. Sci Rep. 2018 Jan 10;8(1):254. doi: 10.1038/s41598-017-18537-x. Sci Rep. 2018. PMID: 29321509 Free PMC article.

2

[Long-standing high-transport membrane as a risk factor for EPS development after PD withdrawal: an analysis based on changes in peritoneal function during and after CAPD withdrawal].

Nakayama M, Ikeda M, Katoh N, Hayakawa H, Numata M, Otsuka Y, Yamamoto R, Yamamoto H, Yokoyama K, Kubo H, Kawaguchi Y, Hosoya T. Nakayama M, et al. Nihon Jinzo Gakkai Shi. 2002 May;44(4):396-401. Nihon Jinzo Gakkai Shi. 2002. PMID: 12073625 Japanese.

3

High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatment.

Yamamoto R, Nakayama M, Hasegawa T, Miwako N, Yamamoto H, Yokoyami K, Ikeda M, Kato N, Hayakawa H, Takahashi H, Otsuka Y, Kawaguchi Y, Hosoya T. Yamamoto R, et al. Among authors: nakayama m. Adv Perit Dial. 2002;18:131-4. Adv Perit Dial. 2002. PMID: 12402604

4

Fifteen cases of encapsulating peritoneal sclerosis related to peritoneal dialysis: a single-center experience in Japan.

Yamamoto H, Nakayama M, yamamoto R, Otsuka Y, Takahashi H, Kato N, Hayakawa H, Hasegawa T, Ikeda M, Yokoyama K, Kawaguchi Y, Mukai H, Hosoya T. Yamamoto H, et al. Among authors: nakayama m. Adv Perit Dial. 2002;18:135-8. Adv Perit Dial. 2002. PMID: 12402605

5

Risk factors and preventive measures for encapsulating peritoneal sclerosis--Jikei experience 2002.

Nakayama M, Yamamoto H, Ikeda M, Hasegawa T, Kato N, Takahashi H, Otsuka Y, Yokoyama K, Yamamoto R, Kawaguchi Y, Hosoya T. Nakayama M, et al. Adv Perit Dial. 2002;18:144-8. Adv Perit Dial. 2002. PMID: 12402607

6

Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment.

Yamamoto R, Otsuka Y, Nakayama M, Maruyama Y, Katoh N, Ikeda M, Yamamoto H, Yokoyama K, Kawaguchi Y, Matsushima M. Yamamoto R, et al. Among authors: nakayama m. Clin Exp Nephrol. 2005 Jun;9(2):148-52. doi: 10.1007/s10157-005-0349-8. Clin Exp Nephrol. 2005. PMID: 15980950

7

High iron storage levels are associated with increased DNA oxidative injury in patients on regular hemodialysis.

Yoshimura K, Nakano H, Yokoyama K, Nakayama M. Yoshimura K, et al. Among authors: nakayama m. Clin Exp Nephrol. 2005 Jun;9(2):158-63. doi: 10.1007/s10157-005-0354-y. Clin Exp Nephrol. 2005. PMID: 15980952 Clinical Trial.

8

[Peritoneal injury and vasculopathy in peritoneal dialysis].

Maruyama Y, Nakayama M. Maruyama Y, et al. Among authors: nakayama m. Nihon Rinsho. 2005 Jun;63 Suppl 6:430-3. Nihon Rinsho. 2005. PMID: 15999747 Review. Japanese. No abstract available.

9

Encapsulating peritoneal sclerosis is a separate entity: Con.

Nakayama M, Maruyama Y, Numata M. Nakayama M, et al. Perit Dial Int. 2005 Feb;25 Suppl 3:S107-9. Perit Dial Int. 2005. PMID: 16048271

10

Quantitative assessment of the peritoneal vessel density and vasculopathy in CAPD patients.

Sherif AM, Nakayama M, Maruyama Y, Yoshida H, Yamamoto H, Yokoyama K, Kawakami M. Sherif AM, et al. Among authors: nakayama m. Nephrol Dial Transplant. 2006 Jun;21(6):1675-81. doi: 10.1093/ndt/gfl054. Epub 2006 Mar 22. Nephrol Dial Transplant. 2006. PMID: 16554330

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,327 results

Search Page

Filters